All posts by imreal

The 7 Keys to Avoid De-Railing P2P Process Transformation


Digital transformation of core business processes is marching forwards. Businesses everywhere are looking to transform customer and supplier relationships and the complex processes that connect them to product and service delivery.

The Purchase to Pay process is inundated with demands to drive more value for the organisation, to make buying simple, and drive down the cost and cycle time of operations.

There are common keys to success at any stage of the journey and whatever transformation or optimization initiative is being considered.

Join Dan French, founder and CEO at Consider Solutions, and Mark Miles, P2P Global Process Owner & Transformation expert to explore the 7 key questions that need serious consideration to ensure P2P process optimization or transformation program stay on the rails and deliver on the business case.

The live event is on Thursday 27th February.

Register attendance here

All registrants will receive a copy of the recording post event.

Share article on social media or email:

VGXI to Manufacture Vaccine Against Novel Coronavirus Under CEPI Funded Collaboration


VGXI Logo

The DNA vaccine manufacturing platform developed by VGXI is an ideal countermeasure against emerging diseases like the current coronavirus outbreak. These vaccines have an extensive safety profile and production can be rapidly scaled-up in response to an epidemic.

VGXI, a world leading contract manufacturer of clinical grade DNA plasmid, announced it will start production of a DNA vaccine against the novel coronavirus (2019-nCoV) that has recently emerged in Wuhan, China under an agreement executed with Inovio Pharmaceuticals. A grant of up to $9 million from the Coalition for Epidemic Preparedness Innovations (CEPI) will fund the vaccine development, manufacturing, and early stage clinical testing as part of the collaborative effort led by Inovio.

“The DNA vaccine manufacturing platform developed by VGXI is an ideal countermeasure against emerging diseases like the current coronavirus outbreak,” stated VGXI CEO Young Park. “These vaccines have an extensive safety profile and production can be rapidly scaled-up in response to an epidemic. Furthermore, the manufacturing process does not involve production of viral particles or viral proteins, unlike traditional vaccines.”

As of January 29, 2020, over 6,000 cases and 130 deaths from the 2019-nCoV virus have been confirmed across mainland China, with other cases identified in over a dozen countries worldwide including 5 in the US. Travel restrictions are currently in place for nearly 60 million people in China in an effort to control the disease spread. Similar to other viruses in the coronavirus family, 2019-nCoV causes flu-like symptoms with severe respiratory illness and viral pneumonia in some cases.

VGXI has demonstrated its ability to support urgent vaccine development timelines in response to recent outbreaks including Ebola, Zika, and a different coronavirus, Middle East Respiratory Syndrome (MERS) in collaboration with its partners including Inovio and GeneOne Life Science. Preparations are already underway at VGXI’s facility in The Woodlands, Texas to begin manufacturing of the DNA vaccine against the 2019-nCoV virus.

ABOUT VGXI, INC.

VGXI, Inc. is a leading provider of manufacturing and development services for DNA vaccines and gene therapies. The company has a reputation of success in manufacturing DNA products under cGMP conditions for clinical trials in the US, EU, Asia, Canada, and Australia, and its cGMP and non-GMP products have passed rigorous reviews by several international regulatory agencies. VGXI’s ability to work with unique requirements and create custom manufacturing solutions is based on its patented manufacturing process, flexible cGMP production facility, and experienced development team. VGXI, Inc. is a wholly-owned subsidiary CDMO of GeneOne Life Science, Inc. To learn more, visit http://www.vgxii.com.

ABOUT GENEONE LIFE SCIENCE

GeneOne Life Science Inc. (“GeneOne” KOSPI: 011000) is an international DNA vaccine and product developer, and leading contract manufacturer of DNA plasmid-based agents for pre-clinical and clinical trials for global companies and institutions. It researches and develops DNA vaccines and products to prevent and treat incurable diseases in South Korea and internationally. The company is headquartered in Seoul, South Korea. VGXI, Inc., GeneOne’s wholly-owned manufacturing subsidiary located in Texas, is the largest pure-play cGMP DNA plasmid manufacturing facility in the world. For more information, visit http://www.genels.com/en.

ABOUT CEPI

CEPI is an innovative partnership between public, private, philanthropic, and civil organizations launched in Davos in 2017 to develop vaccines to stop future epidemics. CEPI has received multi-year funding from Norway, Germany, Japan, Canada, Australia, and the Bill & Melinda Gates Foundation, and Wellcome. CEPI has also received single-year investments from the government of Belgium and the United Kingdom. The European Commission foresees substantial financial contributions to support relevant projects through EC mechanisms. CEPI has reached over US$ 750 million of its $1 billion funding target. Since its launch in January 2017, CEPI has announced three calls for proposals. The first call was for candidate vaccines against Lassa virus, Middle East Respiratory Syndrome coronavirus (MERS-CoV), and Nipah virus. The second call was for the development of platforms that can be used for rapid vaccine development against unknown pathogens. The third call is for candidate vaccines against Rift Valley fever and Chikungunya viruses. To date, CEPI has committed to investing over $310 million in 12 vaccine candidates (five against Lassa virus, four against MERS-CoV, three against Nipah virus) and two vaccine platforms to develop vaccines against Disease X.

ABOUT INOVIO PHARMACEUTICALS, INC.

Inovio (NASDAQ:INO) is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure and/or protect people from diseases associated with HPV, cancer, and infectious diseases. Inovio is the first and only company to have clinically demonstrated that a DNA medicine can be delivered directly into cells in the body via a proprietary smart device to safely produce a robust immune response to destroy and clear high-risk HPV 16 and 18, which are responsible for 70% of cervical cancer, 90% of anal cancer and 69% of vulvar cancer. In addition to HPV, Inovio’s optimized plasmid design and delivery technology has been demonstrated to consistently activate robust and fully functional T cell and antibody responses against targeted cancers and pathogens. Inovio’s most advanced clinical program, VGX-3100, is in Phase 3 development for the treatment of HPV-related cervical pre-cancer. Also in development are Phase 2 immuno-oncology programs targeting HPV-related cancers and GBM, as well as externally funded platform development programs in Zika, MERS, Lassa, and HIV. Partners and collaborators include ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency, GeneOne Life Science, HIV Vaccines Trial Network, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Regeneron, Roche/Genentech, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. For more information, visit http://www.inovio.com.

CAUTIONARY FACTORS THAT MAY AFFECT FUTURE RESULTS

Materials in this press release contain information that includes or is based upon forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Forward-looking statements relate to expectations or forecasts of future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They include words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other words and terms of similar meaning in connection with a discussion of potential future events, circumstances or future operating or financial performance. In particular, these include statements relating to future actions, prospective products or product approvals, future performance or results of current and anticipated products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, and financial results. Any or all of our forward-looking statements here or in other publications may turn out to be incorrect. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining our actual future results. Consequently, no forward-looking statement can be guaranteed, and forward-looking statements may be adversely affected by factors, including general market conditions, competitive product development, product availability, current and future branded and generic competition, federal and state regulations and legislation, manufacturing issues, timing of the elimination of trade buying, patent positions, litigations and investigations. Our actual results may vary materially, and there are no guarantees about the performance or valuation of GeneOne stock. It is also important to read the disclosure notice contained in many of the individual GeneOne documents available on the website, as many contain important information on such cautionary factors as of the date of the individual document. We undertake no obligation to correct or update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our reports.

How To Switch Car Insurance Providers


News Image

“Drivers should consider the advantages and disadvantages of changing their current insurance provider, before making a decision.”, said Russell Rabichev, Marketing Director of Internet Marketing Company.

Changing their insurance provider is a move that drivers have to analyze it carefully. There are many reasons for drivers to change their insurance company, from unfair premiums, up to rude and unsatisfactory customer support. Drivers that want to switch their carriers should consider following these steps:


  • Deciding when to make the move. The ideal time for switching carriers is three to four weeks before policy renewal. This will guarantee the policyholders have enough time to find a policy and to qualify for an early shopper discount.
  • Buy a new policy before canceling the old one. Insurance gaps can be costly, not only when drivers have accidents, but also if their state’s laws penalize registered cars without continuous coverage.
  • Policyholders should consider important life changes. Drivers can change their insurance carrier at any time, but some changes in their lives can make the switch to happen earlier. Important life events, like getting married, moving to a better neighborhood, or the purchase of a better safer vehicle can make the policyholders save money on their premiums.
  • Acknowledge the consequences. Some insurers will charge the policyholders an early cancelation fee. If they stayed with the same insurer for some years, and they decide to cancel their policy, drivers will lose their loyalty discount. Some insurance carriers will offer discounts for new drivers, and a part of the losses that are incurred by switching providers can be compensated.
  • Drivers should consider canceling their old policy in writing. Their old insurance company may ask for the new policy number so that the authorities will know they are continuously covered.
  • Confirm cancelation and ask for a refund. Policyholders should make sure their old insurance company confirms the cancelation. Otherwise, the old insurance company will automatically renew their policy and cancel them for nonpayment. Policyholders can get a refund for their unused premium if they cancel early.


Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

For more information, please visit http://compare-autoinsurance.org.

Share article on social media or email:

The Success In Trucking Expo Returns to the Indianapolis Motor Speedway in June for SITE 2020


The Success In Trucking Expo, hosted by ES, is returning to Indianapolis June 5-6

Everyone who joins us at the SITE 2020 will be able to see how ES stands with the participants in our program and offers support in both the best of times and the most challenging times for this industry. __ ES CEO Paul Williams

Expediter Services (ES), a leader in capacity solutions and ownership opportunities within the trucking industry, is pleased to announce that the company will once again host the Success In Trucking Expo (SITE). For the second consecutive year, ES has chosen the Indianapolis Motor Speedway Complex as the location for the SITE, which will take place June 5-6.

Through the structure and atmosphere that the event established during its inaugural run in 2019, the SITE stands out when compared to the traditional truck shows currently on the calendar in the overall experience it delivers for those in attendance. Led by the efforts of ES, the participating carriers, sponsors and vendors, the SITE offers a much more personal and hands-on event, providing expert perspective on the state of the industry while offering opportunities to become an entrepreneur and grow a business within trucking. The focus of the SITE 2020 will once again be placed on connecting with professional drivers who are looking to take the next step in their careers and become truck owners. The SITE also offers a platform to help address the needs of contract drivers, owner-operators and fleet owners.

The program format of the SITE, with its speakers, roundtable discussions and chosen topics, is once again being structured to share industry knowledge and practical experience to benefit the attendees as they look to build, upgrade and expand their businesses. ES has established a dedicated website that covers all aspects of the SITE 2020, including registration for the event. The website can be accessed through the following link: https://www.successintruckingexpo.com/

“The Success In Trucking Expo is designed to offer solutions to some of the leading challenges in the trucking market today. Whether it’s access to reliable capacity or connecting people with attainable opportunities for truck ownership and steady business growth for entrepreneurs, the 2020 edition of the SITE will be dedicated to providing helpful insights and innovative answers for people looking to achieve greater levels of success in trucking,” said Paul Williams, the Chief Executive Officer of ES. “We are thrilled to bring the SITE back to the home of the Indy 500, and our ES team is focused on creating a meaningful experience for everyone who joins us. We will have a fast-paced and interesting program at the SITE, which provides opportunities for everyone to learn about our ES Community of support. Everyone who joins us at the SITE 2020 will be able to see how ES stands with the participants in our program and offers support in both the best of times and the most challenging times for this industry.”

One of the most unique features about the SITE is that ES is offering free hotel accommodations and free meals for prequalified expo registrants. A limited number of those slots are available for the event, and attendees receiving them will be chosen from the registration submissions ES receives. The registration form for the event can be accessed through the following link: https://www.successintruckingexpo.com/register

Legendary football coach Bobby Bowden will serve as the keynote speaker on the first day of the SITE 2020. With 377 victories in his career, Bowden is one of the winningest coaches in college football history. From 1976-2009, Bowden led Florida State University, and he built the football program into a perennial powerhouse, winning two national championships and earning 22 postseason bowl victories at the helm of FSU. In his 44 seasons overall as a head football coach, Bowden compiled 40 winning seasons, including 33 straight at FSU.

Off the field, Bowden is the author and co-author of several books, and he has served as a leading voice for the Fellowship of Christian Athletes. In fact, the FCA has named an annual award in honor of Bowden. The Bobby Bowden Student-Athlete of the Year Award recognizes one college football player for achievements on the field, in the classroom and in the community.

“We are very proud to welcome Coach Bowden as our keynote speaker for this year’s SITE. His record for achieving success on and off the field as well as his dedication to be of service to others during his lifetime are truly inspirational,” said Jason Williams, President of ES. “We are looking forward to hearing what Coach Bowden will be sharing with us at the SITE. We know his message will hit home with everyone in attendance.”

ES is building a comprehensive program for the SITE 2020. The motor carriers and vendors participating in the SITE have been hand-picked by ES because of their desire to help the attendees in reaching their goals within the trucking industry.

Stoops Freightliner-Quality Trailer, a division of Truck Country, will serve as the title sponsor of the SITE for the second straight year. The ES Community motor carriers participating in the SITE are FedEx Custom Critical, Forward Air and Panther Premium Logistics, a Service of ArcBest. These three companies, all of which were part of the SITE 2019, will once again be the exclusive motor carriers at the SITE. 

Daimler Truck Financial, Detroit Diesel, Equinox Owner-Operator Solutions, Freightliner, Love’s Travel Stops, Paccar Financial, Peterbilt Truck Centers, TA-Petro, TVC Pro Driver, Inc., Vanguard Truck Centers, Volvo Financial Services, Western Star, Crosspoint Power and Refrigeration and the Women In Trucking Association served as vendors at the 2019 SITE. ES officials are expecting the return of last year’s vendors as well as other additions for the SITE 2020.

In addition to the keynote speech by Coach Bowden, the SITE 2020 will feature industry leaders and subject-matter experts sharing their insights through both presentations and discussions. Women In Trucking Association President and CEO Ellen Voie is a part of the speakers list for the SITE 2020 program currently in development by ES.

In November of 2017, ES partnered with the Women In Trucking Association to launch the 150 Business Challenge, a collaborative initiative between the two organizations to create 150 women-owned businesses in transportation. Over the past two-plus years, the 150 Business Challenge is fast approaching 100 new trucking start-ups as a result of participation in the program, which offers an attainable path to financing as well as operational and business support for women who have an interest in a career path within the trucking industry.

Leah Shaver, the Chief Operating Officer of the National Transportation Institute, is one of the industry experts who will be a part of the SITE 2020. Shaver also serves as a host on SiriusXM’s Road Dog Trucking Radio Channel, and she is a member of the Women In Trucking Association’s Board of Directors. She recently participated in the ES Success In Trucking Podcast, discussing changes in the market since the record year of 2018 along with the realities owner-operators often face when launching or attempting to grow a trucking business. During the podcast, Shaver, who serves as a consultant for ES, noted the comprehensive structure of the ES program and the support systems the company has put into place to promote success.

“Truck drivers like freedom and flexibility and that’s why they choose this career. ES is working to help create small businesses with a program that allows the participants to choose the opportunity that is the best fit from a group of partner carriers,” said Shaver. “ES doesn’t stop at financing the truck. The ES Community provides support and leverage. They provide carrier advocacy, allowing a business owner the ability to focus on generating revenue and not on day-to-day issues.

“ES leverages their experience and contacts within the industry to negotiate and make available a variety of other resources and services to their business community,” she added. “The motto at ES is that you never stand alone, and, when you see how ES works with the participants in their programs, it’s clear they live up to that motto every day.”

Since it entered the trucking industry in 2006, ES has utilized a working model that focuses on removing the barriers that hinder professional drivers from becoming truck owners and operating their own small businesses. Through ES, qualified participants in the company’s programs have access to competitive, market-rate financing with a credit-evaluation process that puts an emphasis on attitude, aptitude, work ethic and work history. The ES model has proven to be an effective platform for contract drivers, owner-operators and fleet owners. Today, ES is a leading provider of non-asset capacity within the expedited market, and the company’s platform continues to gain traction within a general trucking market searching for safe, stable, and scalable tractor capacity solutions.

“We are working very hard to do everything that we can to make the SITE 2020 the kind of event that will have a positive impact for everyone who makes the trip to Indianapolis. We are looking forward to working with anyone who is interested in attending. Our goal with the SITE 2020 is to make it a fun, meaningful and memorable experience for everyone involved. Just as we did last year, ES will be providing free hotel accommodations and free meals to prequalified SITE registrants. Don’t wait, there are a limited number of these spots available. Please go to our website, register and start the pre-qualification process. June 5th will be here before you know it,” said Jeff Tacker, the Chief Operating Officer at ES. “If you are interested in true truck ownership with the full support of the ES Community, I would encourage you to visit SuccessInTruckingExpo.com to learn more and to register.”

The ES Success In Trucking Podcast interview with Leah Shaver can be accessed through the following link: https://soundcloud.com/user-668618125/leah-shaver-on-trucking-market-trends

About ES: A full-service, one-stop support company with expertise in financial services, relationship lending and general business support, ES has developed highly effective programs focused on creating opportunities for independent contract drivers and owner-operators in the trucking industry. ES features support in the areas of contract driver services, equipment finance, truck sales, management services and insurance services. In addition to serving as the leading provider of capacity in the expedited sector of trucking, ES also has built a strong network of independent contract drivers, owner-operators, fleet owners and partner carriers within the over-the-road, general trucking sector of the transportation industry. For more information on opportunities and services offered through ES, visit ESsuccessintrucking.com.

Heart to Heart Hospice Increases Service to the Bryan-College Station Metropolitan Area


News Image

“The Bryan-College Station office will help us serve more patients and families in this growing area of Texas.”

Heart to Heart Hospice, one of the country’s largest private providers of hospice care, has added a new location in Texas, expanding its service to those living in the North Houston area.

The new site in the Bryan-College Station area of Texas recently opened to help meet the needs of more people in the North Houston service area. That area, with one office already located in Conroe, covers the counties of Brazos, Northern Grimes, Central Harris, Liberty, Madison, Eastern Montgomery, San Jacinto, Walker and Washington.

The new site is at the following location: 3201 University East, Suite 350, Bryan, Texas, 77802.

“The Bryan-College Station office will help us serve more patients and families in this growing area of Texas,” said Kelly Mitchell, Chief Executive Officer and Founder of Heart to Heart Hospice. “We are excited to be able to provide the compassionate care and support they deserve.”

Since 2003, Heart to Heart Hospice has been serving patients with life-limiting illnesses, as well as their loved ones, across Texas, and in Michigan and Indiana. “When medicine cannot provide a cure, hospice redefines hope in terms of a patient’s quality of life,” noted Mitchell.

Through a team-oriented approach, Heart to Heart cares for the whole person, meeting each patient’s unique needs, while also supporting their caregivers with guidance and encouragement to help make the time together as peaceful as possible.

“Helping our patients remain in the place they call home and keeping them comfortable is what the Heart to Heart care team is trained to do,” said Heather Lumsdon, BSN, RN and Chief Clinical Officer of Heart to Heart Hospice. “We develop a personalized care plan that will honor their wishes and values and truly make a difference for them and their families.”

About Heart to Heart Hospice

Heart to Heart Hospice, founded in 2003, is one of the largest private providers of hospice care in the United States. Headquartered in the Dallas-Fort Worth Metroplex, Heart to Heart provides a broad range of hospice services to patients with life-limiting illnesses across 37 locations in Texas, Michigan and Indiana. At Heart to Heart, we understand both the physical and emotional challenges for our patients and their loved ones and our care team is committed to providing them with what they need most: comfort, support and dignity. Learn more about Heart to Heart Hospice.

Share article on social media or email:

David Kris Joins Cybereason’s Advisory Board as its Newest Member


David Kris, founder of Culper Partners LLC and Cybereason Advisor

“We are thrilled that David is joining our highly regarded group of board advisors offering strategic advice and support to the company during our rapid global expansion. David brings a unique understanding of cybersecurity, data and privacy issues,” said Lior Div, CEO and Co-founder, Cybereason.

Cybereason, creators of the leading Cyber Defense Platform, today announced that David Kris has joined the company as a strategic advisor. In his role on the company’s Advisory Board, Kris will provide the company with strategic advice and help accelerate the company’s go-to-market strategy.

Kris is a former Department of Justice official who held senior positions in the George W. Bush and Obama administrations. He founded Culper Partners LLC in 2017 and is an expert in intelligence, law enforcement and security issues. He has more than 25 years of experience in government, the private sector and academia. Kris is co-author of the leading treatise in the field, National Security Investigations and Prosecutions, as well as the author of several other articles and blog posts. He is a member of the board of directors and a Contributing Editor of the Lawfareblog, adjunct professor at the University of Washington Law School, and a University Affiliate at Georgetown University.

“We are thrilled that David is joining our highly regarded group of board advisors offering strategic advice and support to the company during our rapid global expansion. David brings a unique perspective and understanding of cybersecurity, data and privacy issues and his nearly three-decade career in DC will be invaluable in the coming months,” said Lior Div, CEO and Co-founder, Cybereason.

Kris previously served as the General Counsel of Intellectual Ventures for six years starting in 2011. He was appointed by the President and confirmed by the US Senate as the Assistant Attorney General for National Security in the U.S. Department of Justice from 2009-2011. While at Time Warner from 2003-2009, Kris served as Deputy General Counsel and Chief Ethics and Compliance Officer. From 2000-2003, he served as Associate Deputy Attorney General for National Security within the U.S. Department of Justice. He currently advises two elements of the U.S. Intelligence Community and serves as an amicus curiae to the two Foreign Intelligence Surveillance Courts.

“Cybereason is one of the hottest cybersecurity companies in the world and I’m looking forward to being part of an impressive group of industry stalwarts and visionaries on their advisory board. It’s no coincidence that Cybereason’s meteoric rise is coming at a time when more and more targeted, state-sponsors actors are carrying out sophisticated attacks against the global 1,000 companies and software and services needed to combat risks are offered by the company,” said Kris.

Kris is the recipient of numerous awards and medals, including the National Intelligence Superior Service Medal, the Office of the Secretary of Defense Medal for Exceptional Public Service, the CIA Agency Seal Medal, the Department of Justice Edmund J. Randolph Award, and on two occasions the Attorney General’s Award for Exceptional Service, the Department of Justice’s highest honor.

About Cybereason

Cybereason, creators of the leading Cyber Defense Platform, gives the advantage back to the defender through a completely new approach to cybersecurity. Cybereason offers endpoint prevention, detection and response and active monitoring. The solution delivers multi-layered endpoint prevention by leveraging signature and signatureless techniques to prevent known and unknown threats in conjunction with behavioral and deception techniques to prevent ransomware and fileless attacks. Cybereason is privately held and is headquartered in Boston, with offices in London, Sydney, Tel Aviv, Tokyo, Asia-Pacific and continental Europe.

Learn more: https://www.cybereason.com/

Follow us: Blog | Twitter | Facebook

Media Contact:

Bill Keeler

Senior Director, Global Public Relations

Cybereason

bill.keeler@cybereason.com

(929) 259-3261

Share article on social media or email:



AIM Appoints Leopoldo Valdez as Sales Manager for Central and Western Mexico


AIM Appoints Leopoldo Valdez as Sales Manager for Central and Western Mexico

AIM Solder, a leading global manufacturer of solder assembly materials for the electronics industry, is pleased to announce the appointment of Leopoldo Valdez to the position of Sales Manager for the central and western regions of Mexico.

Leopoldo brings a wealth of engineering and sales experience, along with a customer-focused mindset. With over 18 years of experience in the electronics industry, Leopoldo has extensive knowledge and understanding of production processes, project management and sales. Leopoldo’s knowledge and approach to customer service will be a key part of AIM’s expansion in the Jalisco, Aguascalientes and Zacatecas area.

“We are pleased to welcome Leopoldo to our growing sales team,” said AIM’s National Sales Manager of Mexico, Oscar Lopez. “Leopoldo is very knowledgeable and understands the electronics industry well. We are confident that he will excel at assisting our customers in the central and western regions of Mexico and we look forward to his valuable contributions.”

Based in Guadalajara, Leoplodo may be reached by phone at +52 656 493 22 82 or by email at lvaldez@aimsolder.com.

About AIM

Headquartered in Montreal, Canada, AIM Solder is a leading global manufacturer of assembly materials for the electronics industry with manufacturing, distribution and support facilities located throughout the world. AIM produces advanced solder products such as solder paste, liquid flux, cored wire, bar solder, epoxies, lead-free and halogen-free solder products, and specialty alloys such as indium and gold for a broad range of industries. A recipient of many prestigious SMT industry awards, AIM is strongly committed to innovative research and development of product and process improvement as well as providing customers with superior technical support, service and training. For more information about AIM’s complete line of advanced solder products and global technical services, please visit http://www.aimsolder.com.

Upcoming Events:

February 4-6, 2020 – IPC APEX Expo, San Diego Convention Center, San Diego, CA

March 19, 2020 – SMTA Chihuahua Expo & Tech Forum, Chihuahua, Mexico

March 18-20, 2020 – Productronica China, Shanghai, China

Share article on social media or email:

Catalent Appoints Ricci Whitlow to Lead Clinical Supply Services Business


Ricci Whitlow, President, Clinical Supply Services at Catalent

Ricci Whitlow, President, Clinical Supply Services at Catalent

The clinical supply business is a key component of Catalent’s business strategy, and Ricci rejoins the company following the launch of new initiatives that are helping to guide sponsors in optimizing their clinical trial supply planning and will provide them with new direct-to-patient supply options

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced the appointment of Ricci Whitlow as President, Clinical Supply Services. Ms. Whitlow succeeds Paul Hegwood, who, following a period of transition, plans to retire in March 2020 after a career of nearly 45 years in operations, business development, and engineering roles.

Ms. Whitlow’s position will continue to report to Alessandro Maselli, the company’s President and Chief Operating Officer. As President of the business unit, she will have global responsibility for all aspects of Catalent’s clinical supply business, which, in fiscal 2019, generated $321.4 million in revenue and $84.4 million in Segment EBITDA. Catalent’s clinical supply network includes nine cGMP-certified clinical packaging, storage, and distribution facilities across North America, Europe and Asia, and more than 50 strategically located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management.

Ms. Whitlow has over 25 years’ experience in commercial, operations, and general management roles within the pharmaceutical biologics and medical device industry, and she rejoins Catalent after two-and-a-half years, having previously held the position of VP Operations, overseeing nine manufacturing facilities across North and South America. Her most recent position was with OptiNose, where she served as Senior Vice President of Technical and Corporate Operations, and she has also worked for LifeCell and Johnson & Johnson during her career. Ms. Whitlow holds a master’s degree in business administration from the TRIUM program of NYU Stern School of Business, London School of Economics and HEC Paris; as well as a Bachelor of Science in Industrial Engineering from Texas A&M University. She is also a certified Six Sigma green belt.

“The clinical supply business is a key component of Catalent’s business strategy, and Ricci rejoins the company following the launch of new initiatives that are helping to guide sponsors in optimizing their clinical trial supply planning and will provide them with new direct-to-patient supply options,” commented Mr. Maselli. “Ricci’s expertise in operations and manufacturing, as well as her previous experience at Catalent, make her the ideal person to strengthen and grow this business as the needs of global trials evolve.” He added, “We would like to thank Paul for his service to Catalent, and particularly for his tireless work as a strong advocate for the company’s ‘Patient First’ philosophy. We wish him all the best in his retirement.”

To find out more about Catalent’s clinical supply services, visit http://www.clinical.catalent.com.

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 13,000 people, including over 2,400 scientists and technicians, at more than 35 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

Dr. David Mahjoubi of Ketamine Healing Clinic Named 2020 Top Doctor by Los Angeles Magazine


News Image

I am once again honored to be chosen as a Los Angeles Top Doctor and recognized by such respected and talented physicians in the community. I plan to continue my dedication to helping others realize the benefits of Ketamine therapy, says Dr. David Mahjoubi of Ketamine Healing Clinic of Los Angeles.

Dr. David Mahjoubi, is a highly trained board-certified Anesthesiologist and owner of Ketamine Healing Clinic of Los Angeles located at 1762 Westwood Boulevard suite 320 in Los Angeles, California 90024. Dr. Mahjoubi is uniquely qualified to administer IV infusion therapy of Ketamine to treat depression symptoms as well as anxiety and chronic pain.

Los Angeles Magazine recently recognized Dr. David Mahjoubi in their coveted “Top Doctor” list for 2020. Dr. Mahjoubi, who also achieved this acknowledgment when the Top Doctor list was first produced three years ago, is listed among a respected group of physicians in the Anesthesiology category. Dr. Mahjoubi was chosen based on the respect earned from his peers and colleagues. The magazine issues a thorough nomination and review process conducted by PRS (Professional Research Services), which involves a peer-to-peer survey and voting from practicing physicians throughout Los Angeles County. Inclusion into Los Angeles’ Magazine’s Top Doctors cannot be purchased, and advertising has no influence on the review process. Dr. Mahjoubi’s valued distinction as a Top Doctor will soon appear in the April 2020 issue of Los Angeles Magazine.

Dr. Mahjoubi is most known for his alternative approach to depression treatment. He is among a very elite group of physicians in the United States to use Ketamine to treat depression as well as chronic pain. As an experienced Anesthesiologist, Dr. Mahjoubi understands Ketamine as a safe anesthetic medication that has been used for over half a century. However, Ketamine’s value in treating major depression symptoms is a breakthrough therapy that is highly sought-after at Dr. Mahjoubi’s Los Angeles clinic. Patients receive a calculated protocol of IV Ketamine infusions and may also choose Dr. Mahjoubi’s exclusive Ketamine intranasal spray for supplementary treatment at home. Patients who are not tolerating anti-depressants or resistant to other forms of depression treatment often make ideal candidates for Ketamine. As a non-opioid and non-addictive therapy, Ketamine has also shown valued efficacy for treating chronic pain and fibromyalgia.

“I am once again honored to be chosen as a Los Angeles Top Doctor and recognized by such respected and talented physicians in the community. I plan to continue my dedication to helping others realize the remarkable benefits of Ketamine therapy,” says Dr. David Mahjoubi of Ketamine Healing Clinic of Los Angeles.

More About Dr. David Mahjoubi of Ketamine Healing Clinic of Los Angeles:

David Mahjoubi, MD is a Diplomate of the American Board of Anesthesiology. He earned his Doctor of Medicine at The Chicago Medical School. Dr. Mahjoubi carries over a decade of experience with intravenous Ketamine, beginning from his residency training at the University of Southern California (USC) + Los Angeles County Medical Center. He is the author of multiple publications in the medical field and holds high honors from his educational years. Following his residency, Dr. Mahjoubi joined the Anesthesia Group at Northridge Hospital Medical Center and became the most active user of IV Ketamine for both conscious sedation and general anesthesia cases. After working at surgical centers throughout Southern California, he quickly noted the beneficial mental health effects of IV Ketamine in many patients post-procedurally. Ketamine Healing Clinic of Los Angeles was thus founded, and now provides a highly effective treatment for patients with treatment-resistant depression and chronic pain.

To learn more about IV or intranasal Ketamine treatment from Dr. David Mahjoubi, please contact the Los Angeles office at (424) 278-4241 or (866) 987-7874. You may also visit their website at http://www.ketaminehealing.com.

Share article on social media or email:

Smart Ways To Save Money On Car Insurance


News Image

“Getting online quotes will help you find affordable coverage. Check our website for more car insurance tips”, said Russell Rabichev, Marketing Director of Internet Marketing Company.

Drivers all across the United States have to assume financial responsibility when driving a car. All states, except New Hampshire, require drivers to get car insurance.

Depending on the state’s laws, coverage preferences, driving history and other relevant factors, the coverage will be more or less expensive. Find out how to get cheaper coverage and get free car insurance quotes from http://compare-autoinsurance.org.


  • Use a safe location as a parking spot. Insurance companies analyze the place where the car is parked overnight. They associate that specific location with the chances of being stolen or vandalized. When filling online questionnaires users may be asked if the car is kept at the specified ZIP. Obviously, those who park their cars in a garage or a well-monitored parking lot will get better premiums.
  • Improve the credit score. Clients are asked to provide their credit score range when filling in applications. Obviously, people with Excellent status will get better prices. Improving the credit score is possible, but requires financial counseling from experts. They will present all available strategies.
  • Enroll and graduate approved defensive driving courses. Insurance companies are more than happy to work with safe drivers. People who voluntarily enrolled in defensive driving coursed and graduated them will get a discount. Furthermore, graduating courses will help drivers keep premiums low, by offsetting some future license points.
  • Cooperate with a good insurance agent. Establishing a good professional relationship with an insurance agent will provide multiple long-term benefits. The agent may periodically inform the driver about the latest offers and discounts. The agent will help the client through multiple legal procedures.
  • Compare online car insurance quotes. Online quotes will help drivers check prices from multiple insurance providers. They will also help drivers customize coverage options and create a coverage plan suitable for the driver’s needs and financial resources.


Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

For more information, please visit http://compare-autoinsurance.org.

Share article on social media or email: